Corpus specializes in the design and development of technically complex catheter technologies, with particular expertise in the fields of electrophysiology, structural heart, neurovascular, cardiovascular, peripheral vascular and ENT.
The combined company will continue to operate as Confluent Medical Technologies, and will offer complementary, industry-leading technologies to provide customers with a single-source solution for highly innovative, cost-competitive medical device contract manufacturing, testing, and design services. Confluent Medical has a track record of partnering with the medical device community to deliver medical devices through materials science, engineering, and manufacturing.
“The acquisition of Corpus Medical expands Confluent Medical’s design and manufacturing capabilities into technically complex and advanced catheters. Corpus has extensive technical capabilities in the design and development of products in the electrophysiology, ENT, peripheral vascular, and cardiovascular markets,” said Dean Schauer, president and CEO of Confluent Medical. “We look forward to engaging our customers with our expanded suite of technologies as well as cost-competitive manufacturing.”
“Corpus Medical is thrilled to be joining the Confluent Medical team and combining our expertise in advanced catheter design and development with Confluent’s capabilities to best serve the medical device industry,” said Brice de La Menardiere, president and CEO of Corpus.
Confluent Medical’s expanded portfolio of services includes:
ADVANCED TECHNOLOGY CATHETERS
- Advanced technology in sensor, energy and catheter design and development
- Specializing in the electrophysiology, structural heart, neurovascular, ENT, peripheral vascular, and cardiovascular markets
- Balloon expandable stent and balloon catheter production
- Balloon manufacturing equipment
- High-quality and cost-competitive extrusion
- Medical textile design, development, and contract manufacturing
- Specializing in cardiovascular and orthopedic implants
- Precise polymer component design and production
- Specializing in vascular delivery systems
- Guidewire contract manufacturing
- Specializing in hydrophilic-coated guidewires
- Nitinol component contract manufacturing
- Nitinol device design and testing services
- Nitinol material
Confluent Medical and Corpus Medical are both portfolio companies of Ampersand Capital Partners. Ampersand will continue to be a significant investor in the integrated company, Confluent Medical Technologies.
Confluent Medical Technologies is the largest contract manufacturer of specialized medical devices. With manufacturing facilities in Fremont, Calif.; Laguna Niguel, Calif.; Sunnyvale, Calif.; Warwick, R.I.; and San Jose, Costa Rica, Confluent Medical Technologies has a 20-year track record of partnering with the medical device community and delivering medical devices and components in the aortic intervention, peripheral vascular, ENT, orthopedic/spine, structural heart, electrophysiology, and neurovascular spaces.
Corpus Medical specializes in the design, development, and manufacture of advanced technology catheters for device manufacturers in the electrophysiology, peripheral vascular and cardiovascular markets. With manufacturing facilities in Campbell, Calif., Corpus Medical is a partner to some of the world’s largest device makers.
Founded in 1988, Ampersand is a middle market private equity firm dedicated to growth-oriented investments in the healthcare sector. Ampersand leverages its blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous companies across each of its core healthcare sectors, including Brammer Bio, Confluent Medical, Genewiz, Genoptix, Talecris Biotherapeutics, and Viracor-IBT Laboratories.